Hemato Oncology Testing Market Revenue 2024 to 2034
Hemato Oncology Testing Market Revenue 2024 to 2034
The hemato-oncology testing market size is anticipated to grow from USD 4.00 billion in 2025 to USD 11.47 billion by 2034, with a compound annual growth rate (CAGR) of 12.4% during the forecast period from 2025 to 2034.
Report ID: 10150
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 3.56 Bn
Forecast Year,
USD USD 11.47 Bn
CAGR, 2025 -
12.4%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Hemato Oncology Testing Market Size Analysis
Hemato Oncology Testing Market Size By Offerings 2024 to 2034 (USD )
| Offerings | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Services | 1958.00 | 2224.59 | 2518.69 | 2835.47 | 3172.44 | 3532.52 | 3926.06 | 4370.81 | 4889.44 | 5504.73 | 6233.82 |
| Assay Kits | 1602.00 | 1820.12 | 2060.75 | 2319.93 | 2595.63 | 2890.24 | 3212.23 | 3576.12 | 4000.45 | 4503.87 | 5100.40 |
Hemato Oncology Testing Market Size By Cancer Type 2024 to 2034 (USD )
| Cancer Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Leukemia | 2136.00 | 2426.82 | 2747.67 | 3093.24 | 3460.84 | 3853.66 | 4282.97 | 4768.16 | 5333.94 | 6005.16 | 6800.53 |
| Lymphoma | 1424.00 | 1617.88 | 1831.78 | 2062.16 | 2307.23 | 2569.10 | 2855.31 | 3178.77 | 3555.96 | 4003.44 | 4533.69 |
Hemato Oncology Testing Market Size By Technology 2024 to 2034 (USD )
| Technology | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Polymerase Chain Reaction (PCR) | 890.00 | 1011.18 | 1144.86 | 1288.85 | 1442.02 | 1605.69 | 1784.57 | 1986.73 | 2222.47 | 2502.15 | 2833.55 |
| Immunohistochemistry (IHC) | 640.80 | 728.05 | 824.30 | 927.97 | 1038.25 | 1156.10 | 1284.89 | 1430.45 | 1600.18 | 1801.55 | 2040.16 |
| Next-Generation Sequencing (NGS) | 1068.00 | 1213.41 | 1373.83 | 1546.62 | 1730.42 | 1926.83 | 2141.49 | 2384.08 | 2666.97 | 3002.58 | 3400.27 |
| Cytogenetics (Karyotyping, FISH) | 534.00 | 606.71 | 686.92 | 773.31 | 865.21 | 963.41 | 1070.74 | 1192.04 | 1333.48 | 1501.29 | 1700.13 |
| Other Technologies | 427.20 | 485.36 | 549.53 | 618.65 | 692.17 | 770.73 | 856.59 | 953.63 | 1066.79 | 1201.03 | 1360.11 |
Hemato Oncology Testing Market Size By End User 2024 to 2034 (USD )
| End User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 1780.00 | 2022.35 | 2289.72 | 2577.70 | 2884.03 | 3211.38 | 3569.14 | 3973.47 | 4444.95 | 5004.30 | 5667.11 |
| Academic & Research Institutes | 1246.00 | 1415.65 | 1602.80 | 1804.39 | 2018.82 | 2247.97 | 2498.40 | 2781.43 | 3111.46 | 3503.01 | 3966.98 |
| Others | 534.00 | 606.71 | 686.92 | 773.31 | 865.21 | 963.41 | 1070.74 | 1192.04 | 1333.48 | 1501.29 | 1700.13 |
Hemato Oncology Testing Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1352.80 | 1536.99 | 1740.19 | 1959.05 | 2191.87 | 2440.65 | 2712.55 | 3019.84 | 3378.16 | 3803.27 | 4307.00 |
| Europe | 996.80 | 1132.52 | 1282.24 | 1443.51 | 1615.06 | 1798.37 | 1998.72 | 2225.14 | 2489.17 | 2802.41 | 3173.58 |
| Asia-Pacific | 783.20 | 889.84 | 1007.48 | 1134.19 | 1268.98 | 1413.01 | 1570.42 | 1748.33 | 1955.78 | 2201.89 | 2493.53 |
| Latin America | 249.20 | 283.13 | 320.56 | 360.88 | 403.76 | 449.59 | 499.68 | 556.29 | 622.29 | 700.60 | 793.40 |
| Middle East & Africa | 178.00 | 202.24 | 228.97 | 257.77 | 288.40 | 321.14 | 356.91 | 397.35 | 444.49 | 500.43 | 566.71 |
Hemato Oncology Testing Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
